Abstract
The Ross operation has many unique and intricate features, which need to be defi ned and understood if the operation is to achieve its potential. Although the operation was described nearly 35 years ago, it has continued to evolve through gradual understanding of the complex but elegant anatomic and physiological processes involved in execution of the operation as well as adaptation of the pulmonary valve to its new environment, coupled with the application of sophisticated methods of analysing the results of the operation. All of this has resulted in the accumulation of a large amount of knowledge, which strongly suggests that this operation could have an important, unique and wider role to play in the fi eld of valve surgery provided that certain details are adhered to. Some of this knowledge is reviewed in this editorial. Detailed studies of the form and function of the normal aortic valve have shown that this valve performs extremely sophisticated functions which depend largely on the biological properties of the valve at cellular and molecular level 1-4 and are critically dependent on continued viability of the valve. The Ross operation is the only form of valve replacement which guarantees viability of the valve substitute both in the short and long term. We theorise that this should translate into clinical benefi t both in terms of survival and quality of life. Recent studies using microsimulation to compare the pattern of survival of the Ross operation to the general population, have shown similar pattern of survival in the two groups which is signifi cantly better than that observed after aortic valve replacement using other types of substitutes. 5 Excellent postoperative survival after the Ross operation have been described by several authors 6,7 including the article published in the “journal”. 8 Although it could be argued that these fi ndings are due to patient selection, many of the reported series have included a signifi cant number of high-risk patients such as those with active infective endocarditis or redo operations. Furthermore a prospective randomised trial to compare the Ross operation to homograft has shown enhanced survival after the Ross operation 9 confi rming the notion that continued viability of the valve can translate into major clinical benefi t. Further larger prospective randomised trials, possibly multi centre are needed to confi rm or refute these potentially important preliminary observations. Other aspects of the Ross operation which has evolved concern major technical modifi cations and refi nements of the technique of explantation and insertion of the pulmonary autograft to minimise coronary and myocardial injury during explantation and attempt to eliminate the incidence of late dilatation of the autograft while avoiding the use of any foreign prosthetic material such as Tefl on or Dacron strips which could defeat the purpose of the operation. The original Ross operation involved insertion of the autologous pulmonary valve in the subcoronary position using two suture lines. This technique has the theoretical advantage of retaining normal aortic wall around the autograft which is thought to prevent progressive dilatation of the autograft root. This technique however has the potential of distorting the autograft. Although valves inserted by this technique can last for periods of up to 35 years, 10 we have observed calcifi cation in one of the cusps of the autograft which had to be due to abnormal movements of the cusps secondary to distortion. The technique of full aortic (or pulmonary) root replacement was originally introduced to maintain the exact relationship of the semilunar valve mechanism 11 and have been shown to be an independent predictor of better survival and less degeneration following aortic homograft valve replacement. 12 If that technique is used however, we believe that it is essential to use multiple interrupted sutures for the lower suture line with scalloping of the autograft to allow the hinge mechanism to be supported by the native aortic annulus. Another evolutionary point in the Ross operation is the inherent capacity to adapt to the new environment by altering its structure and physical properties. 13 This however, does not occur immediately after the operation and therefore the newly implanted autograft root should not be subjected to pressure higher than 110/80 which could predispose to progressive root dilatation and/or chronic dissection of the arterial wall of the pulmonary autograft root.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.